# Hypophosphatemia
 
Hypophosphatemia – Peter Thorne

Background

-   PO <sub>4</sub>
    -3
    \< 2.3mg/dL
-   Common Causes
    -   -   Internal redistribution, reduced intestinal absorption
        -   Malnourished pts: refeeding syndrome and intracellular
            movement/use of phos
        -   Insulin moves phos intracellular as does respiratory
            alkalosis
        -   Phos binders on purpose or inadvertently (calcium, aluminum,
            magnesium antacids)
        -   Excessive loss (diarrhea, CRRT, increased urinary excretion)
        -   Proximal tubular dysfunction such as in Fanconi Syndrome
        -   Hyperparathyroidism causes renal phos wasting
        -   Post-parathyroidectomy leading to hungry bone syndrome
        -   Vitamin D deficiency or resistance
-   PO <sub>4</sub>
    -3
    is primarily found in bone and intracellular space
-   Required for metabolic pathways (ATP production!)
-   Most renal reabsorption occurs in proximal tubule via
    sodium-phosphate cotransporter

Presentation

-   Mild Hypophosphatemia (serum >2.0) rarely symptomatic
-   PO <sub>4</sub> <sup>-3</sup>
    \< 2.0: Muscle weakness
-   PO <sub>4</sub> <sup>-3</sup>
    \< 1.0: Heart failure, respiratory failure, rhabdomyolysis, seizures
-   Failure to wean from ventilator

Evaluation

-   Urine
    PO <sub>4</sub> <sup>-3</sup>
    level if cause not readily apparent
-   Calculate
    Fe
    PO <sub>4</sub> <sup>-3</sup>
    (\[U
    PO <sub>4</sub> <sup>-3</sup>
    x PCr x 100\]/\[P
    PO <sub>4</sub> <sup>-3</sup>
    x UCr\]).
    -   -   Fe
            PO <sub>4</sub> <sup>-3</sup>
            \< 5% = normal renal response to hypophos: redistribution or
            ↓
            absorption
        -   Fe
            PO <sub>4</sub> <sup>-3</sup>
            \> 5% = renal phos wasting

Management

-   Caution repleting pts with impaired renal function: start with half
    suggested dose
-   If K <sup>+</sup> > 4 and patient requires IV repletion, may need to
    use sodium
    PO <sub>4</sub> <sup>-3</sup>
    in place of K <sup>+</sup>
    PO <sub>4</sub> <sup>-3</sup>
    IV; po preferred unless severe or symptomatic, or patient cannot
    take po
-   K-
    Phos
    neutral: oral, each 250mg tablet has 8 mmol of
    PO <sub>4</sub> <sup>-3</sup>
    and 1.1mEq of K <sup>+</sup>
-   K <sup>+</sup>
    PO <sub>4</sub> <sup>-3</sup>
    : IV, each mL has 3mmol
    PO <sub>4</sub> <sup>-3</sup>
    , 4.4 meq K <sup>+</sup>
-   Na <sup>+</sup>
    PO <sub>4</sub> <sup>-3</sup>
    : IV, each mL has 3mmol
    PO <sub>4</sub> <sup>-3</sup>
-   IV
    repletion
    is diluted in 250mL NS or D5W and infused over 4-6 hrs
-   PO <sub>4</sub> <sup>-3</sup>
    \>1.5: PO: 40 – 80 mmol
    K <sup>+</sup>
    Phos neutral (aim for 1 mmol/kg) divided into 3-4 doses/day
-   PO <sub>4</sub> <sup>-3</sup>
    1.25 - 1.5: oral 100 mmol
    K <sup>+</sup>
    PO <sub>4</sub> <sup>-3</sup>
    neutral in 3-4 divided doses if asymptomatic
-   IV: 30 mmol K <sup>+</sup>
    PO <sub>4</sub> <sup>-3</sup>
    over 6 hours
    (aim for 0.4mmol/kg)
    if symptomatic
-   PO <sub>4</sub> <sup>-3</sup>
    \<1.25: IV: 80mmol
    K <sup>+</sup>
    Phos over approximately 12 hours (aim for 0.5mmol/kg)
    -   -   Check serum
            PO <sub>4</sub> <sup>-3</sup>
            2-12 hrs after last dose of
            PO <sub>4</sub> <sup>-3</sup>
            to determine if additional needs
